Related Experiment Video
Updated: Jul 15, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Treatment of plastic bronchitis
Sushma Nayar1, Ramesh Parmar, Snehal Kulkarni
1Department of Pathology, Frontier Lifeline, and Dr KM Cherian Heart Foundation, Chennai, India. divya_s35@hotmail.com
The Annals of Thoracic Surgery
|April 28, 2007
Summary
Plastic bronchitis with type I casts can occur after palliative surgery for cyanotic heart disease. Thoracic duct ligation may not fully resolve this condition, indicating complex post-surgical airway issues.
Area of Science:
- Cardiology
- Thoracic Surgery
- Pulmonary Medicine
Background:
- Plastic bronchitis is a rare but serious complication following palliative surgery for cyanotic heart disease.
- Type II (acellular) casts are the more commonly documented form in this clinical context.
Observation:
- This case report details a patient who developed type I (cellular) plastic bronchitis casts post-palliative cardiac surgery.
- The patient underwent ligation of the thoracic duct in an attempt to manage the condition.
Findings:
- Despite thoracic duct ligation, the type I plastic bronchitis casts did not completely resolve.
- This suggests that factors beyond lymphatic drainage may contribute to cast formation in this surgical population.
Implications:
- The findings highlight the need for further investigation into the pathophysiology of type I plastic bronchitis after cyanotic heart disease surgery.
- Alternative or adjunctive treatment strategies may be required for complete resolution.
- This case contributes to understanding the diverse presentations and management challenges of plastic bronchitis in pediatric cardiac surgery patients.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:24Chest Physiotherapy
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...